🇺🇸 FDA
Patent

US 6187775

Acridone-derived compounds useful as antineoplastic and antiretroviral agents

expired A61PA61P31/00A61P31/12

Quick answer

US patent 6187775 (Acridone-derived compounds useful as antineoplastic and antiretroviral agents) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P31/00, A61P31/12, A61P31/18, A61P35/00